Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Patent: 5,541,206

« Back to Dashboard

Patent 5,541,206 protects KALETRA and NORVIR and is included in seven NDAs. There have been zero Paragraph IV challenges on Norvir and There are seven tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

Protection for KALETRA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,541,206

Title: Retroviral protease inhibiting compounds
Abstract:A retroviral protease inhibiting compound of the formula: ##STR1## is disclosed.
Inventor(s): Kempf; Dale J. (Libertyville, IL), Norbeck; Daniel W. (Crystal Lake, IL), Sham; Hing Leung (Gurnee, IL), Zhao; Chen (Gurnee, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Application Number:08/423,387
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abbvie
KALETRA
lopinavir; ritonavir
CAPSULE;ORAL021226Sep 15, 2000RXYes5,541,206*PED<disabled>Y
Abbott
NORVIR
ritonavir
CAPSULE;ORAL020680Mar 1, 1996DISCNNo5,541,206*PED<disabled>Y
Abbvie
NORVIR
ritonavir
CAPSULE;ORAL020945Jun 29, 1999RXYes5,541,206*PED<disabled>Y
Abbvie
KALETRA
lopinavir; ritonavir
SOLUTION;ORAL021251Sep 15, 2000RXYes5,541,206*PED<disabled>Y
Abbvie
NORVIR
ritonavir
SOLUTION;ORAL020659Mar 1, 1996RXYes5,541,206*PED<disabled>Y
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 5,541,206

Country Document Number Publication Date
World Intellectual Property Organization (WIPO)9217176Oct 15, 1992
World Intellectual Property Organization (WIPO)9323361Nov 25, 1993
World Intellectual Property Organization (WIPO)9414436Jul 07, 1994
United States of America5541334Jul 30, 1996
United States of America5545750Aug 13, 1996
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc